--- title: "China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year" type: "News" locale: "en" url: "https://longbridge.com/en/news/262581763.md" description: "According to the Zhitong Finance APP, China Resources Pharmaceutical announced its Dong'e Ejiao performance for the nine months ending September 30, 2025, with total operating revenue of RMB 4.766 billion, an increase of 4.41% year-on-year; net profit of RMB 1.277 billion, an increase of 10.77% year-on-year" datetime: "2025-10-24T09:12:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262581763.md) - [en](https://longbridge.com/en/news/262581763.md) - [zh-HK](https://longbridge.com/zh-HK/news/262581763.md) generator: "portal-rs" --- # China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-year According to the Zhitong Finance APP, China Resources Pharmaceutical (03320) released the performance report of Dong'e Ejiao for the nine months ending September 30, 2025, with total operating revenue of RMB 4.766 billion, an increase of 4.41% year-on-year; net profit of RMB 1.277 billion, an increase of 10.77% year-on-year ### Related Stocks - [000423.CN](https://longbridge.com/en/quote/000423.CN.md) ## Related News & Research - [Alibaba’s AI Spending Spree Intensifies — Surprise Stock Sale Has Analysts Asking Why](https://longbridge.com/en/news/296767766.md) - [Foreign worker numbers to stay controlled despite business pressure](https://longbridge.com/en/news/296762549.md) - [EDM Announces Results of the Annual General Meeting | EDMFF Stock News](https://longbridge.com/en/news/296781083.md) - [Cheng Shin Rubber: 2026H1 net income surged 43.8% year-over-year, driven by higher revenue and improved margins](https://longbridge.com/en/news/296745040.md) - [E-Lead Electronic: AR-HUD leadership, diversified products, and stable financials support global growth](https://longbridge.com/en/news/296460681.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**